Testicular carcinoma

Postgraduate Medical Journal

Volumn 73, Issue 862, 1997, Pages 481-486

  O'Callaghan, Ann ^a   Mead, Graham M ^a  

^a ROYAL SOUTH HANTS HOSPITAL   (United Kingdom)

Author keywords

Germ cell tumours; Testicular cancer

Indexed keywords

ANTINEOPLASTIC METAL COMPLEX; CISPLATIN;

CANCER INCIDENCE; GERM CELL TUMOR; MALE; MULTIMODALITY CANCER THERAPY; NONHUMAN; REVIEW; SEMINOMA; TESTIS CARCINOMA;

EID: 0030853666     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.73.862.481     Document Type: Review

References (23)

1. Cancer statistics registrations, England and Wales 1989. London: Office of Population of Census and Surveys. Series MB1 no 29, 1994.
2. Forman D, Pike MC, Davey G, et al. Aetiology of testicular cancer: association with congenital abnormalities, age at puberty, infertility, and exercise. BMJ 1984; 308: 1393-9.
3. Von de Masse H, Rorth M, Walborn-Jorgessen S, et al. Carcinoma in situ of the contralateral testis in patients with testicular germ cell cancer. A study of 27 cases in 500 patients. BMJ 1986; 293: 1398-401.
4. True LD, Rosai J. Tumours of the testis. In: Mc Gee JO'D, Isaacson PG, Wright NA, eds. Oxford textbook of pathology. Oxford: Oxford University Press, 1992; pp 1554-62.
5. Freedman LS, Parkinson MC, Jones WG, et al. Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone: a Medical Research Council collaborative study. Lancet 1987; 8554: 294-8.
6. Rodriguez E, Mathew S, Reuter V, Ilson DH, Bosl GJ, Chaganti RSK. Cytogenetic analysis of 124 prospectively ascertained male germ cell tumours. Cancer Res 1992; 52: 2285-91.
7. Bates SE, Longo DL. Use of serum markers in cancer diagnosis and management. Semin Oncol 1987; 14: 102-38.
8. Mead GM, Stenning SP, Parkinson MC, et al. The second Medical Research Council study of prognostic factors in non-seminomatous germ cell tumours. J Clin Oncol 1992; 10: 85-94.
9. Mead GM, Stenning SP, Cook P, et al. International consensus on germ cell classification. A prognostic factor based staging system for metastatic germ cell cancers. J Clin Oncol 1997; 14: 1106-13.
10. Hamilton C, Horwich A, Easton D, et al. Radiotherapy for stage I seminoma testis: results of treatment and complications. Radiother Oncol 1986; 6: 115-20.
11. Fossa SD, Aass N, Kaalhus O. Radiotherapy for testicular seminoma stage 1: treatment results and long term post-irradiation morbidity in 365 patients. Int J Radiat Oncol Biol Phys 1989; 16: 383-8.
12. Read G, Stenning SP, Cullen MH, et al. Medical Research Council prospective study of surveillance for stage I testicular teratoma. J Clin Oncol 1992; 10: 1762-8.
13. Cullen MH, Stenning SP, Parkinson MC, et al. Short course adjuvant chemotherapy in high risk stage I non-seminoma germ cell tumour of the testis. A Medical Research Council report. J Clin Oncol 1997; 15: 594-603.
14. Einhorn LH. Treatment of testicular cancer: a new and improved model. J Clin Oncol 1990; 8: 1977-81.
15. Garrow GC, Johnson DH. Treatment of good risk metastatic testicular cancer. Semin Oncol 1992; 19: 159-65.
16. Bajorin DF, Sarosdy MF, Pfister DG, et al. Randomised trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good risk germ cell tumours: a multi-institutional study. J Clin Oncol 1993; 11: 598-606.
17. Kaye SB, Mead GM, Fossa S, et al. An MRC/EORTC randomised trial in poor prognosis metastatic teratoma, comparing BEP with BOP/VIP (abstract). Proc ASCO 1995; 14: 246.
18. Cullen M, De Wit R, Bodrogi I, et al. An MRC/EORTC randomised trial in poor prognosis metastatic teratoma, comparing treatment with/without filgrastim (G-CSF) (abstract). Proc ASCO 1995; 14: 245.
19. Bokemeyer C, Harstrick A, Ruther U, et al. Sequential high-dose VIP-chemotherapy plus peripheral blood stem cell (PBSC) support in advanced germ cell cancer (abstract). Proc ASCO 1995; 14: 230.
20. Horwich A, Dearnaley DP, Duchesne GM, et al. Simple non-toxic treatment of advanced metastatic seminoma with carboplatin. J Clin Oncol 1989; 7: 1150-6.
21. Jansen RLH, Sylvester R, Sleyfer DT, et al. Long term follow up of non-seminomatous testicular cancer patients with mature teratoma or carcinoma at postchemotherapy surgery. Eur J Cancer 1991; 27: 695-8.
22. Horwich A. Salvage chemotherapy of germ cell tumours. Br J Cancer 1995; 71: 901-3.
23. Motzer RJ, Chou TC, Schwartz L, et al. Paclitaxel in germ cell cancer. Semin Oncol 1995; 22(supp 6:) 12-5.